These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28943189)

  • 1. Pro: Activated Clotting Time Should Be Monitored During Heparinization For Vascular Surgery.
    Goldhammer JE; Zimmerman D
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1494-1496. PubMed ID: 28943189
    [No Abstract]   [Full Text] [Related]  

  • 2. Con: Activated Clotting Time Should Not Be Monitored During Heparinization for Vascular Surgery.
    Wolo E; Herman C
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1497-1499. PubMed ID: 29336967
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques.
    Mabry CD; Thompson BW; Read RC; Campbell GS
    Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery.
    Mabry CD; Thompson BW; Read RC
    Am J Surg; 1979 Dec; 138(6):894-900. PubMed ID: 507308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin levels and activated clotting time (ACT) during open heart surgery.
    Stenbjerg S; Berg E; Albrechtsen OK
    Scand J Haematol; 1981 Apr; 26(4):281-4. PubMed ID: 7336144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated clotting time during cardiopulmonary bypass: is repetition necessary during open heart surgery?
    Neema PK; Sinha PK; Rathod RC
    Asian Cardiovasc Thorac Ann; 2004 Mar; 12(1):47-52. PubMed ID: 14977742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
    Ural K; Owen C
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1727-1729. PubMed ID: 27641953
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.
    Hellstern P; Bach J; Simon M; Saggau W
    J Extra Corpor Technol; 2007 Jun; 39(2):81-6. PubMed ID: 17672188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Con: The Hepcon HMS Should Not Be Used Instead of Traditional Activated Clotting Time to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
    Gilly G; Trusheim J
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1730-1732. PubMed ID: 27751763
    [No Abstract]   [Full Text] [Related]  

  • 11. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.
    Koster A; Despotis G; Gruendel M; Fischer T; Praus M; Kuppe H; Levy JH
    Anesth Analg; 2002 Jul; 95(1):26-30, table of contents. PubMed ID: 12088937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of aprotinin on heparinized whole blood activated clotting time and whole blood prothrombin time].
    Wen Z; Zhu F; He X; Xiong S; He S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):304-6. PubMed ID: 9868081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time.
    Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M
    Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Heparin Anticoagulation Measured Using i-STAT and Hemochron Activated Clotting Time.
    Maslow A; Chambers A; Cheves T; Sweeney J
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1603-1608. PubMed ID: 29503117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation control during neuroradiological interventions with ACT (activated clotting time)].
    Berlis A; Schumacher M
    Rofo; 1999 Apr; 170(4):378-83. PubMed ID: 10341797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with activated clotting time (ACT) controlled heparinization in open heart surgery.
    Albrechtsen OK; Stenbjerg S; Berg E
    Thorac Cardiovasc Surg; 1982 Apr; 30(2):109-12. PubMed ID: 6179241
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic heparinization during peripheral vascular surgery: thromboelastographic, activated coagulation time, and heparin titration monitoring.
    Martin P; Greenstein D; Gupta NK; Walker DR; Kester RC
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):150-2. PubMed ID: 8204807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
    Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
    Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
    Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.